FULGENT GENETICS, INC. Other Comprehensive Income (Loss), Net of Tax
FULGENT GENETICS, INC. (FLGT) reported Other Comprehensive Income (Loss), Net of Tax of -$2.40 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-07-30.
Financial Statements › Income Statement › Unrealized Gains
us-gaap:OtherComprehensiveIncomeLossNetOfTax · last filed 2026-07-30
- FULGENT GENETICS, INC. other comprehensive income (loss), net of tax for the quarter ending 2026-06-30 was -$2.40M, a 268.65% decline year-over-year.
- FULGENT GENETICS, INC. other comprehensive income (loss), net of tax for the quarter ending 2026-03-31 was -$2.91M, a 161.46% decline year-over-year.
- FULGENT GENETICS, INC. other comprehensive income (loss), net of tax for the quarter ending 2025-09-30 was $856.00K, a 91.65% decline year-over-year.
- FULGENT GENETICS, INC. other comprehensive income (loss), net of tax for the quarter ending 2025-06-30 was $1.43M, a 609.45% increase year-over-year.
- FULGENT GENETICS, INC. other comprehensive income (loss), net of tax for fiscal 2025 was $7.79M.
- FULGENT GENETICS, INC. other comprehensive income (loss), net of tax for fiscal 2024 was -$1.72M, a 107.29% decline from fiscal 2023.
- FULGENT GENETICS, INC. other comprehensive income (loss), net of tax for fiscal 2023 was $23.52M.
- FULGENT GENETICS, INC. other comprehensive income (loss), net of tax for fiscal 2022 was -$22.61M.
| Period end | Other Comprehensive Income (Loss), Net of Tax 3 month | Other Comprehensive Income (Loss), Net of Tax 6 month | Other Comprehensive Income (Loss), Net of Tax 9 month | Other Comprehensive Income (Loss), Net of Tax 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$2.40M 10-Q · filed 2026-07-30 | -$5.31M derived: sum of 2 quarters · filed 2026-07-30 | ||
| 2026-03-31 | -$2.91M 10-Q · filed 2026-07-30 | |||
| 2025-12-31 | $7.79M 10-K · filed 2026-02-27 | |||
| 2025-09-30 | $856.00K 10-Q · filed 2025-11-07 | $2.28M derived: sum of 2 quarters · filed 2026-07-30 | $7.01M derived: sum of 3 quarters · filed 2026-07-30 | |
| 2025-06-30 | $1.43M 10-Q · filed 2026-07-30 | $6.16M derived: sum of 2 quarters · filed 2026-07-30 | ||
| 2025-03-31 | $4.73M 10-Q · filed 2026-07-30 | |||
| 2024-12-31 | -$1.72M 10-K · filed 2026-02-27 | |||
| 2024-09-30 | $10.26M 10-Q · filed 2025-11-07 | $10.46M derived: sum of 2 quarters · filed 2025-11-07 | $8.05M derived: sum of 3 quarters · filed 2025-11-07 | |
| 2024-06-30 | $201.00K 10-Q · filed 2025-11-07 | -$2.20M derived: sum of 2 quarters · filed 2025-11-07 | ||
| 2024-03-31 | -$2.40M 10-Q · filed 2025-11-07 | |||
| 2023-12-31 | $23.52M 10-K · filed 2026-02-27 | |||
| 2023-09-30 | $3.79M 10-Q · filed 2024-11-08 | -$310.00K derived: sum of 2 quarters · filed 2024-11-08 | $5.19M derived: sum of 3 quarters · filed 2024-11-08 | |
| 2023-06-30 | -$4.10M 10-Q · filed 2024-11-08 | $1.40M derived: sum of 2 quarters · filed 2024-11-08 | ||
| 2023-03-31 | $5.50M 10-Q · filed 2024-11-08 | |||
| 2022-12-31 | -$22.61M 10-K · filed 2025-02-28 | |||
| 2022-09-30 | -$4.43M 10-Q · filed 2023-11-03 | -$14.77M derived: sum of 2 quarters · filed 2023-11-03 | -$26.39M derived: sum of 3 quarters · filed 2023-11-03 | |
| 2022-06-30 | -$10.35M 10-Q · filed 2023-11-03 | -$21.96M derived: sum of 2 quarters · filed 2023-11-03 | ||
| 2022-03-31 | -$11.62M 10-Q · filed 2023-11-03 | |||
| 2021-12-31 | -$1.09M 10-K · filed 2024-02-28 | |||
| 2021-09-30 | $28.00K 10-Q · filed 2022-11-07 | -$11.00K derived: sum of 2 quarters · filed 2022-11-07 | -$665.00K derived: sum of 3 quarters · filed 2022-11-07 | |
| 2021-06-30 | -$39.00K 10-Q · filed 2022-11-07 | -$693.00K derived: sum of 2 quarters · filed 2022-11-07 | ||
| 2021-03-31 | -$654.00K 10-Q · filed 2022-11-07 | |||
| 2020-12-31 | $292.00K 10-K · filed 2023-02-28 | |||
| 2020-09-30 | -$442.00K 10-Q · filed 2021-11-09 | $800.00K derived: sum of 2 quarters · filed 2021-11-09 | $461.00K derived: sum of 3 quarters · filed 2021-11-09 | |
| 2020-06-30 | $1.24M 10-Q · filed 2021-11-09 | $903.00K derived: sum of 2 quarters · filed 2021-11-09 | ||
| 2020-03-31 | -$339.00K 10-Q · filed 2021-11-09 | |||
| 2019-12-31 | $181.00K 10-K · filed 2022-02-28 | |||
| 2019-09-30 | -$24.00K 10-Q · filed 2020-11-09 | $84.00K derived: sum of 2 quarters · filed 2020-11-09 | $214.00K derived: sum of 3 quarters · filed 2020-11-09 | $236.00K derived: sum of 4 quarters · filed 2020-11-09 |
| 2019-06-30 | $108.00K 10-Q · filed 2020-11-09 | $238.00K 10-Q · filed 2019-08-12 | $260.00K derived: sum of 3 quarters · filed 2020-11-09 | $285.00K derived: sum of 4 quarters · filed 2020-11-09 |
| 2019-03-31 | $130.00K 10-Q · filed 2020-11-09 | $152.00K derived: sum of 2 quarters · filed 2020-11-09 | $177.00K derived: sum of 3 quarters · filed 2020-11-09 | $182.00K derived: sum of 4 quarters · filed 2020-11-09 |
| 2018-12-31 | $22.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-13 | $47.00K derived: sum of 2 quarters · filed 2020-03-13 | $52.00K derived: sum of 3 quarters · filed 2020-03-13 | $9.00K 10-K · filed 2020-03-13 |
| 2018-09-30 | $25.00K 10-Q · filed 2019-11-08 | $30.00K derived: sum of 2 quarters · filed 2019-11-08 | -$13.00K 10-Q · filed 2018-11-09 | -$67.00K derived: sum of 4 quarters · filed 2019-11-08 |
| 2018-06-30 | $5.00K 10-Q · filed 2019-11-08 | -$38.00K 10-Q · filed 2019-08-12 | -$92.00K derived: sum of 3 quarters · filed 2019-11-08 | -$14.00K derived: sum of 4 quarters · filed 2019-11-08 |
| 2018-03-31 | -$43.00K 10-Q · filed 2019-11-08 | -$97.00K derived: sum of 2 quarters · filed 2019-11-08 | -$19.00K derived: sum of 3 quarters · filed 2019-11-08 | $34.00K derived: sum of 4 quarters · filed 2019-11-08 |
| 2017-12-31 | -$54.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-22 | $24.00K derived: sum of 2 quarters · filed 2019-03-22 | $77.00K derived: sum of 3 quarters · filed 2019-03-22 | $59.00K 10-K · filed 2019-03-22 |
| 2017-09-30 | $78.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-13 | $131.00K derived: sum of 2 quarters · filed 2017-11-13 | $113.00K 10-Q · filed 2017-11-13 | |
| 2017-06-30 | $53.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-14 | $35.00K 10-Q · filed 2017-08-14 | ||
| 2017-03-31 | -$18.00K 10-Q · filed 2017-05-09 | |||
| 2016-12-31 | -$103.00K 10-K · filed 2018-03-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| Aclarion, Inc. (ACON) | United States | $0.008B | |
| BioNexus Gene Lab Corp (BGLC) | $0.004B |